Hip Replacement News and Research

RSS

C-section rates in US stabilize after eight years of steady increase

A new report on trends in women's health in the United States reveals the national C-section rate has held steady at 33 percent since 2009, leveling off after eight years of steady increase that was in part driven by scheduled, elective surgeries and a trend for increasing the repeat C-section.

19 Jun 2012

Multi-modal approach reduces pain and side effects of medication following joint replacement surgery

Reducing acute post-surgical pain and side effects of medications for patients undergoing knee and hip replacement surgery is the focus of a new multi-modal approach at Greenwich Hospital in Greenwich, Connecticut.

19 Jun 2012

BioInvent, ThromboGenics announce results from TB-402 Phase IIb trial on VTE

ThromboGenics NV and co-development partner BioInvent International announce today the results from a Phase IIb trial comparing TB-402, a long acting anticoagulant, against rivaroxaban, an oral anticoagulant.

5 Jun 2012

Hip arthroplasty pseudotumors ‘cause for great concern’

Pseudotumors may be 10 times more common in patients after metal-on-metal hip resurfacing and total hip replacement than thought, suggest Dutch researchers.

1 Jun 2012

Arthritis rates set to soar

According to new estimates the number of people with arthritis is set to soar with predictions that 1,500,000 Scots will be living with the condition by 2030.

10 May 2012

Janssen submits XARELTO sNDA with FDA to reduce risk of stent thrombosis in ACS patients

Janssen Research & Development, LLC announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO, an oral anticoagulant, to reduce the risk of stent thrombosis in patients with Acute Coronary Syndrome.

10 May 2012

AHA recognizes HHS’ Charla de Lupus program with HAVE

The American Hospital Association (AHA) has recognized Hospital for Special Surgery's Charla de Lupus (Lupus Chat) program with its Hospital Award for Volunteer Excellence.

5 May 2012

Researchers develop new kind of hip implant

Hip replacement is one of the most frequent operations carried out in Germany. Each year, doctors implant some 200,000 artificial hip joints. Often the artificial hips need to be replaced just ten years later. In the future, a new implant currently being developed using high technology materials could help prevent premature revision surgeries.

5 May 2012

Out-of-state insurers show no interest in Georgia

A new law that allows Georgians to buy health insurance plans approved by other states was envisioned as free-market solution that would lower prices and increase choices. So far, the law has failed to produce results: Not a single insurer is offering a policy under the new law. "Nobody has even asked to be approved to sell across state lines," Georgia Insurance Commissioner Ralph Hudgens said.

30 Apr 2012

Evergreen Healthcare employs transanal endoscopic microsurgery for colorectal tumor removal

Evergreen Healthcare today announced that it has successfully integrated a colorectal procedure called transanal endoscopic microsurgery to its growing suite of minimally invasive surgical options, reducing the need for major surgery and providing patients with faster recovery times.

6 Apr 2012

No cancer risk with metal on metal hip replacements: Study

Cancer risk was just one of the fears linked to the implants. Regulators have already called for them to be monitored closely following reports of high failure rates. Tiny metal ions made up of cobalt and chromium are thought to break off from the implants and leak into the blood, with fears that this leads to muscle and bone damage, and neurological issues.

4 Apr 2012

FDA seeks expert advice on risks and benefits of MoM hip systems

The U.S. Food and Drug Administration today announced that it is seeking expert scientific and clinical advice on the risks and benefits of metal-on-metal (MoM) hip systems as well as potential patient and practitioner recommendations on the use of MoM hip systems and the management of patients implanted with such devices. FDA will discuss these issues at a two-day expert advisory panel meeting on June 27-28, 2012.

30 Mar 2012

Rare total shoulder replacement performed using rotator cuff sparing approach

On Tuesday, March 6, 2012, Ryan Simovitch, M.D., Board Certified and fellowship trained orthopedic surgeon, performed one of the first successful total shoulder replacements with a rotator cuff sparing technique in South Florida. Jupiter Medical Center remains on the leading edge of orthopedics, offering orthopedic surgeons, state-of-the-art facilities, and comprehensive rehabilitation services to help patients return to an active and healthy lifestyle.

29 Mar 2012

Rivaroxaban found safe and effective in pulmonary embolism

Rivaroxaban has been found to be effective in the prevention of venous thromboembolism (VTE) after orthopedic surgery, for the prevention of stroke in AF (Atrial fibrillation) patients, and as additional therapy to conventional antiplatelet therapy in ACS (Acute coronary syndrome) patients.

27 Mar 2012

Rivaroxaban safer, effective than standard therapy in treating PE

A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism - a blockage of lung blood vessels usually caused by a clot - and showed comparable efficacy, according to data from the EINSTEIN-PE trial presented today at the American College of Cardiology's 61st Annual Scientific Session.

27 Mar 2012

Only 21 states require public reporting of hospital data on surgical site infections

Only 21 states require public reporting of hospital data on surgical site infections and, even when disclosure is mandated, the information is often not easily accessible to patients who could use it to make decisions about their medical care, according to new Johns Hopkins research.

17 Mar 2012

‘All-metal’ hips may fail more often study finds as experts call for a ban

Metal-on-metal hips were developed to be more durable than traditional implants, which combine a ceramic or metal ball with a plastic socket. But recent experience suggests they may actually do worse, prompting the recall of one device made by Johnson & Johnson that critics argue should never have been allowed on the market.

14 Mar 2012

Abbott, GenLab collaborate to develop new assay for PLEX-ID automated microbial identification system

Abbott announced today it will collaborate with Genetics Laboratory, Inc. on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections.

5 Mar 2012

Metal hip implants need monitoring annually: MHRA issues guidelines

The UK Medicines and Healthcare products Regulatory Agency advised that patients with certain artificial hips need annual tests to check for metal ions and MRIs if they show symptoms. The new guidelines follow reports from doctors of swelling and tissue damage in some patients with metal-on-metal hip implants. The update applies to those in Britain with a hip replacement with a head diameter of 36 millimetres or more. The MHRA said on Tuesday that around 49,000 UK patients with large-head hip implants out of 65,000 with all-metal hips were in a high-risk category.

1 Mar 2012

FDA assigns Priority Review designation to JRD's XARELTO sNDA

Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).

27 Feb 2012